<DOC>
	<DOCNO>NCT01894581</DOCNO>
	<brief_summary>The United States high prevalence obesity among country survey 2012 Organization Economic Cooperation Development . Maternal obesity link anovulation , menstrual cycle abnormality , subfertility , fetal loss , obstetrical complication congenital anomaly . Changes reproductive hormone diminish oocyte quality also demonstrate . A gap knowledge exist mechanism underlie harmful effect poorly understand specific treatment exist . This proposal test hypothesis dietary omega-3 fatty acid ( FA ) improve output hypothalamicpituitary- ovarian axis obese woman . The investigator perform paired assessment supplementation 10 obese 10 normal weight woman . To test pituitary hypothalamic output , investigator examine luteinizing hormone ( LH ) follicle-stimulating hormone ( FSH ) responsiveness frequent blood sampling . To test corpus luteum function , investigator examine urinary reproductive hormone ( E1c , estrone conjugate , pregnanediol glucuronide ( Pdg ) ) entire menstrual cycle . The investigator ultimate goal collect preliminary data adequately power randomize control trial .</brief_summary>
	<brief_title>Effects Dietary Omega-3 Fatty Acids Reproductive Hormones Obese Women</brief_title>
	<detailed_description />
	<mesh_term>Hormones</mesh_term>
	<criteria>1 . Age 1842 study entry 2 . Regular menstrual cycle every 2540 day 3 . BMI least 30 kg/m2 ( obese ) 18.5 25 kg/m2 ( normal ) 4 . Good general health 5 . Prolactin thyroidstimulating hormone ( TSH ) within normal laboratory range screen , baseline hemoglobin &gt; 11 gm/dl . 1 . Diagnosis polycystic ovary syndrome ( ultrasound hyperandrogenic symptom ) 2 . Fish seafood allergy hypersensitivity ( e.g. , anaphylactic reaction ) omega3acid ethyl ester component formulation 3 . Coagulopathy receive therapeutic anticoagulation ( due potential interaction omega3 FA ) 4 . History chronic disease affect hormone production , metabolism clearance ( include diabetes mellitus ) 5 . Abnormal renal liver function screen 6 . Current use thiazolidinediones metformin ( know interact reproductive hormone ) 7 . Use hormone affect hypothalamic output ( HPO ) axis ( hormonal contraceptive ) within three month entry 8 . Strenuous exercise ( &gt; 4 hour intense physical activity per week ) 9 . Pregnancy 10 . Breastfeeding 11 . Current active attempt conceive 12 . History significant recent weight loss gain</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>